NK Pharmacare Limited - Accounts to registrar (filleted) - small 18.1

NK Pharmacare Limited - Accounts to registrar (filleted) - small 18.1

NK PHARMACARE LIMITED - Company Information

Print Friendly Version

IRIS Accounts Production v18.1.2.30 08692147 Board of Directors 1.10.16 30.9.17 30.9.17 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure086921472016-09-30086921472017-09-30086921472016-10-012017-09-30086921472015-09-30086921472015-10-012016-09-30086921472016-09-3008692147ns15:EnglandWales2016-10-012017-09-3008692147ns14:PoundSterling2016-10-012017-09-3008692147ns10:Director12016-10-012017-09-3008692147ns10:PrivateLimitedCompanyLtd2016-10-012017-09-3008692147ns10:SmallEntities2016-10-012017-09-3008692147ns10:AuditExemptWithAccountantsReport2016-10-012017-09-3008692147ns10:SmallCompaniesRegimeForDirectorsReport2016-10-012017-09-3008692147ns10:SmallCompaniesRegimeForAccounts2016-10-012017-09-3008692147ns10:FullAccounts2016-10-012017-09-3008692147ns10:OrdinaryShareClass12016-10-012017-09-3008692147ns10:Director22016-10-012017-09-3008692147ns10:CompanySecretary12016-10-012017-09-3008692147ns10:RegisteredOffice2016-10-012017-09-3008692147ns5:CurrentFinancialInstruments2017-09-3008692147ns5:CurrentFinancialInstruments2016-09-3008692147ns5:ShareCapital2017-09-3008692147ns5:ShareCapital2016-09-3008692147ns5:RetainedEarningsAccumulatedLosses2017-09-3008692147ns5:RetainedEarningsAccumulatedLosses2016-09-3008692147ns5:PlantMachinery2016-10-012017-09-3008692147ns5:PlantMachinery2016-09-3008692147ns5:PlantMachinery2017-09-3008692147ns5:PlantMachinery2016-09-3008692147ns5:CurrentFinancialInstrumentsns5:WithinOneYear2017-09-3008692147ns5:CurrentFinancialInstrumentsns5:WithinOneYear2016-09-3008692147ns10:OrdinaryShareClass12017-09-30


REGISTERED NUMBER: 08692147 (England and Wales)















Unaudited Financial Statements for the Year Ended 30th September 2017

for

NK PHARMACARE LIMITED
NK PHARMACARE LIMITED (REGISTERED NUMBER: 08692147)






Contents of the Financial Statements
for the year ended 30th September 2017




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3

Chartered Accountants' Report 5

NK PHARMACARE LIMITED

Company Information
for the year ended 30th September 2017







DIRECTORS: Mrs N K Patel
K Patel





SECRETARY: K Patel





REGISTERED OFFICE: 2 Burton House
Repton Place
White Lion Road
Amersham
Buckinghamshire
HP7 9LP





REGISTERED NUMBER: 08692147 (England and Wales)





ACCOUNTANTS: Jacquards
2 Burton House
Repton Place
White Lion Road
Amersham
Buckinghamshire
HP7 9LP
Page 1
NK PHARMACARE LIMITED (REGISTERED NUMBER: 08692147)

Balance Sheet
30th September 2017

2017 2016
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 - 367

CURRENT ASSETS
Debtors 5 7,139 7,314
Cash at bank 57,212 52,627
64,351 59,941
CREDITORS
Amounts falling due within one year 6 69,448 59,086
NET CURRENT (LIABILITIES)/ASSETS (5,097 ) 855
TOTAL ASSETS LESS CURRENT
LIABILITIES
(5,097
)
1,222

PROVISIONS FOR LIABILITIES - 73
NET (LIABILITIES)/ASSETS (5,097 ) 1,149

CAPITAL AND RESERVES
Called up share capital 7 100 100
Retained earnings (5,197 ) 1,049
SHAREHOLDERS' FUNDS (5,097 ) 1,149

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30th September 2017.

The members have not required the company to obtain an audit of its financial statements for the year ended 30th September 2017 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the
Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at
the end of each financial year and of its profit or loss for each financial year in accordance with the
requirements of Sections 394 and 395 and which otherwise comply with the requirements of the
Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors on 26th June 2018 and were signed on its
behalf by:



K Patel - Director


The notes form part of these financial statements

Page 2
NK PHARMACARE LIMITED (REGISTERED NUMBER: 08692147)

Notes to the Financial Statements
for the year ended 30th September 2017

1. STATUTORY INFORMATION

NK Pharmacare Limited is a private company, limited by shares , registered in England and Wales.
The company's registered number and registered office address can be found on the Company
Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts,
rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement,
except to the extent that it relates to items recognised in other comprehensive income or directly in
equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been
enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at
the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods
different from those in which they are recognised in financial statements. Deferred tax is measured
using tax rates and laws that have been enacted or substantively enacted by the year end and that are
expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable
that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 .

Page 3 continued...
NK PHARMACARE LIMITED (REGISTERED NUMBER: 08692147)

Notes to the Financial Statements - continued
for the year ended 30th September 2017

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1st October 2016
and 30th September 2017 1,470
DEPRECIATION
At 1st October 2016 1,103
Charge for year 367
At 30th September 2017 1,470
NET BOOK VALUE
At 30th September 2017 -
At 30th September 2016 367

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2017 2016
£    £   
Other debtors 7,139 7,314

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2017 2016
£    £   
Taxation and social security 10,789 14,496
Other creditors 58,659 44,590
69,448 59,086

7. CALLED UP SHARE CAPITAL


Allotted, issued and fully paid:
Number: Class: Nominal 2017 2016
value: £    £   
100 Ordinary £1.00 100 100

8. ULTIMATE CONTROLLING PARTY

The ultimate controlling parties are Mr K Patel and Mrs N K Patel, who are the directors and each own
50% issued share capital of the company.

9. FIRST YEAR ADOPTION

The financial statements for the period are the first financial statements prepared in accordance with
FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland. The reported
financial position and financial performance for the previous period are not affected by the transition to
FRS 102.

Page 4
Chartered Accountants' Report to the Board of Directors
on the Unaudited Financial Statements of
NK Pharmacare Limited

The following reproduces the text of the report prepared for the directors in respect of the company's
annual unaudited financial statements. In accordance with the Companies Act 2006, the company is
only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain
other primary statements and the Report of the Directors are not required to be filed with the
Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval
the financial statements of NK Pharmacare Limited for the year ended 30th September 2017 which comprise
the Income Statement, Other Comprehensive Income, Balance Sheet, Statement of Changes in Equity and
the related notes from the company's accounting records and from information and explanations you have
given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the Board of Directors of NK Pharmacare Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of NK Pharmacare Limited and state those matters that we have agreed to state to the Board of Directors of NK Pharmacare Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than NK Pharmacare Limited and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that NK Pharmacare Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of NK Pharmacare Limited. You consider that NK Pharmacare Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of NK Pharmacare Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Jacquards
2 Burton House
Repton Place
White Lion Road
Amersham
Buckinghamshire
HP7 9LP


26th June 2018

This page does not form part of the statutory financial statements

Page 5